FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Tirzepatide has already been filed for approval ... as a replacement for its $5 billion once-weekly GLP-1 drug Trulicity (dulaglutide), facing increased competition from Novo Nordisk's Ozempic ...

Lilly's head of diabetes, Mike Mason, said on the company's results call that the rollout of Mounjaro (tirzepatide ... Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing ...

Available Ozempic alternatives: dulaglutide (generic Trulicity), Metformin ... that contains the same active ingredient as Mounjaro: tirzepatide. However, unlike Mounjaro and Ozempic, Zepbound ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

Several other formulations with unique structures and properties are being investigated in ongoing clinical trials including albiglutide, semaglutide, dulaglutide and ITCA650. Published and ...

The Galaxy S25 Ultra, Samsung's newest premium flagship, is a powerhouse. It boasts Qualcomm's powerful Snapdragon 8 Elite chip, a 6.9-inch LTPO OLED display, a 5,000mAh battery, and S-Pen support ...

Jannik Sinner vs Alexander Zverev highlights: Jannik Sinner claimed his second consecutive Australian Open championship on Sunday, never facing a single break point and using his complete game to ...